Two patients with multiple sclerosis presenting with symptomatic selective IgM deficiency
CH50, IgG, and IgA were within normal limits but IgM was decreased (30 - 33 mg/dL) with a poor pneumococcal vaccine response as well as a decreased response to in vitro tetanus recall antigen despite intact tetanus antibody titers..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:139 |
---|---|
Enthalten in: |
The journal of allergy and clinical immunology - 139(2017), 2, Seite AB214 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hanks, Mary E [VerfasserIn] |
---|
Links: |
---|
BKL: | |
---|---|
Themen: |
RVK: |
---|
doi: |
10.1016/j.jaci.2016.12.693 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC199042970X |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC199042970X | ||
003 | DE-627 | ||
005 | 20230514100857.0 | ||
007 | tu | ||
008 | 170303s2017 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jaci.2016.12.693 |2 doi | |
028 | 5 | 2 | |a PQ20170301 |
035 | |a (DE-627)OLC199042970X | ||
035 | |a (DE-599)GBVOLC199042970X | ||
035 | |a (PRQ)c719-37589367eff3e38b21d338d58b24644a5fac246e80cf7810b01135abb1f86ab10 | ||
035 | |a (KEY)0036902020170000139000200214twopatientswithmultiplesclerosispresentingwithsymp | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q DNB |
084 | |a XA 52000 |q AVZ |2 rvk | ||
084 | |a 44.45 |2 bkl | ||
084 | |a 44.78 |2 bkl | ||
100 | 1 | |a Hanks, Mary E |e verfasserin |4 aut | |
245 | 1 | 0 | |a Two patients with multiple sclerosis presenting with symptomatic selective IgM deficiency |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
520 | |a CH50, IgG, and IgA were within normal limits but IgM was decreased (30 - 33 mg/dL) with a poor pneumococcal vaccine response as well as a decreased response to in vitro tetanus recall antigen despite intact tetanus antibody titers. | ||
650 | 4 | |a Patients | |
650 | 4 | |a Vaccines | |
650 | 4 | |a Antigens | |
650 | 4 | |a Tetanus | |
650 | 4 | |a Multiple sclerosis | |
700 | 1 | |a Shepherd, Meagan W |4 oth | |
773 | 0 | 8 | |i Enthalten in |t The journal of allergy and clinical immunology |d Amsterdam [u.a.] : Elsevier, 1971 |g 139(2017), 2, Seite AB214 |w (DE-627)129294780 |w (DE-600)121011-7 |w (DE-576)014488264 |x 0091-6749 |7 nnns |
773 | 1 | 8 | |g volume:139 |g year:2017 |g number:2 |g pages:AB214 |
856 | 4 | 1 | |u http://dx.doi.org/10.1016/j.jaci.2016.12.693 |3 Volltext |
856 | 4 | 2 | |u http://search.proquest.com/docview/1867933409 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_130 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4219 | ||
936 | r | v | |a XA 52000 |
936 | b | k | |a 44.45 |q AVZ |
936 | b | k | |a 44.78 |q AVZ |
951 | |a AR | ||
952 | |d 139 |j 2017 |e 2 |h AB214 |